StudyFinder

REACT-AF: The Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation

Recruiting

This research is being done to assess whether it is safe and effective to stop oral anticoagulation medications (a blood-thinning medication) during prolonged periods of normal heart rhythm in participants with infrequent episodes of atrial fibrillation (AF).

I'm interested

Male or Female
18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• history of symptomatic or asymptomatic paroxysmal or persistent atrial fibrillation (AF) and a moderate risk of stroke
Exclusion Criteria:

• documented prior stroke (ischemic or hemorrhagic) or transient ischemic attack (TIA)
• reversible causes of AF (e.g., cardiac surgery, pulmonary embolism, untreated hyperthyroidism).

Device: AFSW Guided DOAC, Drug: Continuous DOAC therapy

Heart & Vascular

AF, Clinics and Surgery Center (CSC), Stroke

Maddy Chopp - chopp015@umn.edu
Lin Yee Chen
PHASE3
SITE00002070
See this study on ClinicalTrials.gov

Back